Development and Validation of Voriconazole Concentration by LC‐MS‐MS: Applied in Clinical Implementation
Journal of Clinical Laboratory Analysis2016Vol. 31(1)
Citations Over TimeTop 20% of 2016 papers
Santirat Prommas, Apichaya Puangpetch, Nuttawut Jenjirattithigarn, Sumonrat Chuwongwattana, Thawinee Jantararoungtong, Napatrupron Koomdee, Siwalee Santon, Monpat Chamnanphon, Chonlaphat Sukasem
Abstract
This method is applicable for routine monitoring of patients' VRZ plasma level with fast and accurate runtime to assess CYP2C19 genotype.
Related Papers
- → Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model(2009)16 cited
- → In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species(1996)124 cited
- → Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer(2005)17 cited
- → In vitroactivity of voriconazole against Mexican oral yeast isolates(2009)8 cited
- Comparison of Therapeutic Efficacy of Fluconazole and Voriconazole in the Treatment of Severe Pulmonary Fungal Infection(2013)